MORPHIC HOLDING, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.07 USD | +0.32% |
|
+0.29% | -2.80% |
| Apr. 25 | Morphic Holding, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
Chart calendar Morphic Holding, Inc.
544489b0bf895d2efb4df83db6674.3AVPCanTkKbdwWfRS9mCyFMp28tZ8rUJUuK5oJpsrg0.mUwZU9ij4_ap8FfnOqP2rD55vq1htoBiNaHSk6M46Vzqbjpg4OvHzK2QDA~a1e8286f8abdc8aaaed99c4d1e4b3a8f
Upcoming events on Morphic Holding, Inc.
Past events on Morphic Holding, Inc.
| 2024-04-25 07:00 am | Q1 2024 Earnings Release |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-12 | Leerink Partners Global Biopharma Conference |
| 2024-03-06 10:30 am | TD Cowen Health Care Conference - Fireside Chat |
| 2024-03-06 09:10 am | TD Cowen Health Care Conference - Panel |
| 2024-02-22 07:00 am | Q4 2023 Earnings Release |
| 2024-01-10 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-30 09:10 am | Evercore ISI HealthCONx Conference |
| 2023-11-14 12:00 pm | Jefferies London Healthcare Conference - Fireside Chat |
| 2023-11-03 07:00 am | Q3 2023 Earnings Release |
| 2023-10-14 | UEG Week Conference |
| 2023-10-12 07:45 am | MORF-057 Phase 2a Study Results Call |
| 2023-09-06 08:00 am | Wells Fargo Healthcare Conference |
| 2023-08-10 11:30 am | Canaccord Genuity Growth Conference |
| 2023-08-03 07:05 am | Q2 2023 Earnings Release |
| 2023-06-07 01:00 pm | Jefferies Global Healthcare Conference |
| 2023-06-01 01:00 pm | Annual General Meeting |
| 2023-05-17 10:30 am | RBC Capital Markets Global Healthcare Conference |
| 2023-04-25 08:00 am | MORF-057 EMERALD-1 Phase 2a Study Results Call |
| 2023-04-25 06:59 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,0 22,8 -25.69% | 44,9 45,6 -1.52% | 19,8 22,6 -12.27% | 70,8 67,4 5.01% | 0,52 0,50 3.33% | 0,29 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -178 -175 -1.39% | -229 |
|
EBIT Million USD | Released Forecast Spread | -47,0 -38,2 -22.96% | -47,2 -45,8 -3.02% | -95,8 -92,9 -3.1% | -63,4 -71,3 11.05% | -179 -177 -1.06% | -233 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,4 -34,1 -24.57% | -45,6 -43,7 -4.29% | -95,5 -90,4 -5.71% | -59,0 -68,9 14.4% | -152 -153 0.6% | -218 |
|
Net income Million USD | Released Forecast Spread | -43,3 -33,8 -28.19% | -45,0 -43,6 -3.26% | -95,5 -92,3 -3.52% | -59,0 -68,4 13.73% | -152 -153 0.47% | -200 |
|
EPS USD | Released Forecast Spread | -2,69 -3,00 10.33% | -1,47 -1,41 -4.4% | -2,67 -2,58 -3.56% | -1,55 -1,79 13.52% | -3,59 -3,39 -5.93% | -4,01 |
| Announcement Date | 27/02/20 | 01/03/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,38 3,22 -25.97% | 60,2 3,65 1548.3% | 2,06 3,10 -33.63% | 6,14 2,70 127.02% | 0,52 2,16 -75.87% | 0,00 1,72 - | 0,00 0,50 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,08 | 0,25 |
|
EBITDA Million USD | Released Forecast Spread | -49,2 -46,7 -5.2% | -53,3 -52,1 -2.25% | -55,4 | -58,9 | -62,7 | |||||||
|
EBIT Million USD | Released Forecast Spread | -31,7 -29,8 -6.16% | 26,4 -32,8 180.42% | -31,5 -32,6 3.52% | -26,6 -34,4 22.83% | -39,2 -32,5 -20.56% | -45,3 -38,4 -17.84% | -44,7 -46,6 3.91% | -49,4 -47,7 -3.72% | -53,6 -51,8 -3.55% | -56,6 | -59,8 | -63,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,5 -29,5 -6.57% | 26,8 -32,4 182.86% | -30,0 -32,2 6.76% | -24,3 -34,2 28.85% | -36,1 -31,8 -13.69% | -38,9 -37,3 -4.27% | -36,1 -43,5 16.99% | -40,6 -42,5 4.37% | -45,2 -49,3 8.26% | -53,1 | -55,7 | -58,2 |
|
Net income Million USD | Released Forecast Spread | -31,5 -29,8 -5.7% | 26,8 -32,1 183.59% | -30,0 -32,2 6.85% | -24,4 -33,7 27.75% | -36,1 -31,9 -13.14% | -39,0 -37,4 -4.45% | -36,2 -43,2 16.14% | -40,7 -42,3 3.61% | -45,3 -47,5 4.58% | -50,9 | -52,9 | -55,0 |
|
EPS USD | Released Forecast Spread | -0,85 -0,81 -4.94% | 0,68 -0,85 179.77% | -0,78 -0,83 6.02% | -0,64 -0,87 26.72% | -0,90 -0,81 -11.11% | -0,92 -0,87 -5.48% | -0,73 -0,95 23.52% | -0,94 -0,84 -12.33% | -0,91 -0,93 1.74% | -1,01 | -1,05 | -1,08 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 23/02/23 | 25/04/23 | 03/08/23 | 03/11/23 | 22/02/24 | 25/04/24 | - | - | - |
More events
Past sector events for Morphic Holding, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MORF Stock
- Calendar Morphic Holding, Inc.
